ELVT Labs
ELVT Labs operates an AI-powered bioactive discovery platform that decodes plant chemistry to identify, validate, and develop novel natural compounds for human health. Its proprietary ELVT-01 AI engine analyzes mass spectrometry data to map molecular fingerprints, targeting the 99% of plant chemistry never before catalogued. The platform covers sleep, performance, and skin applications, delivering patent-ready ingredients for brand partnerships or licensing.
- Biotechnology
- Artificial Intelligence
- Drug Discovery & Therapeutics
- Chemical Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
The wellness and bioactive ingredients market is constrained by a lack of genuine innovation, with less than 5% of ingredients launched in the last 20 years being truly novel. Brands compete on advertising spend rather than science, and 99% of plant chemistry remains unexplored despite nature being the origin of 65% of all small-molecule therapeutics, leaving a massive gap in defensible, science-backed product development.
Solution
ELVT Labs operates an AI-powered bioactive discovery platform that systematically decodes plant chemistry to identify, validate, and develop novel natural compounds. The platform uses ELVT-01, a proprietary AI engine, to read the molecular fingerprint of every compound in a plant via mass spectrometry, achieving breakthrough accuracy in identifying chemical structures, including ones never previously catalogued. After identifying promising candidates, the platform conducts bioactivity screening and lead selection, then advances the strongest leads through preclinical validation, human proof-of-concept, formulation, IP filing, and regulatory clearance. The end result is a market-ready, patent-protected ingredient that brands can partner on or license directly, turning target health outcomes into defensible commercial assets in a fraction of traditional time and cost.
Target Audience
Consumer wellness and supplement brands seeking science-backed, patent-protected ingredients to differentiate their product lines, as well as health and nutrition companies looking for novel bioactive compounds with clinical validation.
Features
- ELVT-01 AI engine that analyzes mass spectrometry data to decode molecular fingerprints and identify novel chemical structures with breakthrough accuracy
- Systematic mapping of unexplored plant chemical space, targeting the 99% of plant chemistry never before catalogued
- End-to-end development pipeline covering bioactivity screening, lead selection, preclinical validation, and human proof-of-concept studies
- IP filing and regulatory clearance support to deliver patent-ready, market-ready ingredients
- Platform designed to scale across multiple health domains, initially targeting sleep, performance, and skin applications
- Partnership and licensing models that allow brands to access finished, validated ingredients